Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care

University Hospitals (UH)

Status: Terminated

Conditions: Venous Thromboembolism; Cancer

Treatments: Drug: nadroparin

Study type: Observational

Funder types: Other

Identifiers

NCT00303407

SPOT 99/54

Details and patient eligibility

About

To determine the efficacy and to measure the complications of prophylactic anticoagulation using low-molecular weight heparin in adult cancer patients under palliative care

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Cancer patients in palliative care
• Patients fully informed about their condition
• Signed informed consent
• No exclusion criteria

Exclusion criteria

• Absence of advanced cancer
• Cancer previously cured
• Venous thromboembolism diagnosed within 6 months prior to inclusion
• Absence of discerning capacity
• Active anti-thrombotic treatment with heparins or coumarines
• Thrombocytopenia <50G/l
• PTT >45sec
• TP<35%
• Active bleeding
• Renal failure <20ml/min
• Past history of heparin-induced thrombocytopenia